Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Compound 112531
2. Desacetylvinblastine Amide
3. Eldisine
4. Enison
5. Nsc 245467
6. Nsc-245467
7. Nsc245467
8. Sulfate, Vindesine
9. Vindesin
10. Vindesine
1. 59917-39-4
2. Vindesine Sulfate Salt
3. Fildesin (tn)
4. Vindesinesulfatesalt
5. Eldesine
6. Eldisine
7. Desacetylvinblastine Amide Sulfate
8. Chebi:32295
9. Dava
10. Vindesine (sulfate)
11. 3-carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine Sulfate (1:1) (salt)
12. 3-carbamoyl-o(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine Sulfate
13. Fildesi
14. Vindesine Sulfate- Bio-x
15. Desacetyl Vinblastine Amide
16. Schembl4285
17. Dsstox_cid_29000
18. Dsstox_rid_83265
19. Dsstox_gsid_49074
20. Vindesine Sulfate(rg)
21. Mls001424270
22. Vindesine Sulfate Salt Hydrate
23. Vdsdesacetyl Vinblastine Amide
24. Vindesine Sulfate (jan/usan)
25. Chembl2105882
26. Dtxsid0049074
27. C43h57n5o11s
28. Hms2052b03
29. N-a-boc-d-2,4-diaminobutyricacid
30. Tox21_113632
31. S2440
32. Akos015895863
33. Ccg-101151
34. Nc00401
35. Ac-24198
36. Bv164524
37. Smr000469153
38. Cas-59917-39-4
39. Hy-129071
40. Cs-0103448
41. D01769
42. 917v394
43. Q-100693
| Molecular Weight | 852.0 g/mol |
|---|---|
| Molecular Formula | C43H57N5O11S |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 7 |
| Exact Mass | 851.37752882 g/mol |
| Monoisotopic Mass | 851.37752882 g/mol |
| Topological Polar Surface Area | 248 Ų |
| Heavy Atom Count | 60 |
| Formal Charge | 0 |
| Complexity | 1650 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
Registration Number : 218MF10518
Registrant's Address : Rue Fonds Jean Pa(^)ques, 8 1435 Mont-Saint-Guibert Belgium
Initial Date of Registration : 2006-05-18
Latest Date of Registration :


FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
Registration Number : 218MF10518
Registrant's Address : Rue Fonds Jean Pa(^)ques, 8 1435 Mont-Saint-Guibert Belgium
Initial Date of Registration : 2006-05-18
Latest Date of Registration : 2018-10-26
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
About the Company : MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported b...
About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...
About the Company : Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have...

About the Company : VINKEM - One Stop Solution for complete range ofOncology In-house API's & Finished dosage injectables in liquid vials andlyophilized form.State of Art cGMP facility with DMF and ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Details:
Prednisone is a Steroid drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Lead Product(s):
Prednisone,Vincristine Sulfate,Pegylated-Asparaginase,Bortezomib,Cytarabine,Cyclophosphamide,Daunorubicin,Mercaptopurine,Methotrexate,
Therapeutic Area: Oncology
Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Steroid Sponsor:
Shanghai Children's Medical Center | Beijing Children's Hospital | Children's Hospital of Scow University | West China Second University Hospital | Nanjing Children's Hospital | Qilu Hospital of Shandong University | Tianjin Medical University Cancer Inst
Deal Size: Inapplicable
Upfront Cash: Inapplicable
Deal Type: Inapplicable
January 12, 2023

Lead Product(s) :
Prednisone,Vincristine Sulfate,Pegylated-Asparaginase,Bortezomib,Cytarabine,Cyclophosphamide,Daunorubicin,Mercaptopurine,Methotrexate,
Therapeutic Area :
Oncology Highest Development Status :
Phase III Partner/Sponsor/Collaborator :
Shanghai Children's Medical Center | Beijing Children's Hospital | Children's Hospital of Scow University | West China Second University Hospital | Nanjing Children's Hospital | Qilu Hospital of Shandong University | Tianjin Medical University Cancer Inst Deal Size : Inapplicable Deal Type : Inapplicable
Details : Prednisone is a Steroid drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Precursor T-Cell Lymphoblastic Leukemia-Lymphoma.
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
January 12, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
IBI301 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Lymphoma, Large B-Cell, Diffuse.
Lead Product(s): IBI301,Cyclophosphamide,Doxorubicin Hydrochloride,Vindesine Sulfate,Prednisone
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 16, 2016

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IBI301,Cyclophosphamide,Doxorubicin Hydrochloride,Vindesine Sulfate,Prednisone
Therapeutic Area : Oncology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : IBI301 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Lymphoma, Large B-Cell, Diffuse.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 16, 2016

Details:
Prednisone is a Steroid drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Lead Product(s):
Prednisone,Vincristine Sulfate,Pegylated-Asparaginase,Cytarabine,Cyclophosphamide,Daunorubicin,Mercaptopurine,Methotrexate,Dexamethasone,Pegasparaginase,
Therapeutic Area: Oncology
Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Steroid Sponsor:
Shanghai Children's Medical Center | Tongji Hospital | West China Second University Hospital | Qilu Hospital of Shandong University | Tianjin Medical University Cancer Institute and Hospital | Children's Hospital of Soochow University | Nanjing Children's
Deal Size: Inapplicable
Upfront Cash: Inapplicable
Deal Type: Inapplicable
July 27, 2016

Lead Product(s) :
Prednisone,Vincristine Sulfate,Pegylated-Asparaginase,Cytarabine,Cyclophosphamide,Daunorubicin,Mercaptopurine,Methotrexate,Dexamethasone,Pegasparaginase,
Therapeutic Area :
Oncology Highest Development Status :
Phase III Partner/Sponsor/Collaborator :
Shanghai Children's Medical Center | Tongji Hospital | West China Second University Hospital | Qilu Hospital of Shandong University | Tianjin Medical University Cancer Institute and Hospital | Children's Hospital of Soochow University | Nanjing Children's Deal Size : Inapplicable Deal Type : Inapplicable
LBL-2016 for Children or Adolescents in China
Details : Prednisone is a Steroid drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
July 27, 2016

Details:
Obinutuzumab is a Antibody drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Lymphoma, Large B-Cell, Diffuse.
Lead Product(s): Obinutuzumab,Doxorubicin Hydrochloride,Cyclophosphamide,Prednisone,Bleomycin Sulphate,Vindesine Sulfate,Vincristine Sulfate
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Antibody, Unconjugated
Sponsor: F. Hoffmann-La Roche
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 07, 2012

Lead Product(s) : Obinutuzumab,Doxorubicin Hydrochloride,Cyclophosphamide,Prednisone,Bleomycin Sulphate,Vindesine Sulfate,Vincristine Sulfate
Therapeutic Area : Oncology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : F. Hoffmann-La Roche
Deal Size : Inapplicable
Deal Type : Inapplicable
GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma
Details : Obinutuzumab is a Antibody drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Lymphoma, Large B-Cell, Diffuse.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Inapplicable
August 07, 2012

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Eldisine
Dosage Form : Powder For Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 16/03/1982
Application Number : 42863
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Eldisine
Dosage Form : Powder For Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 06/12/1985
Application Number : 19851206000060
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Suspensed
Registration Country : Spain
Brand Name : Enison
Dosage Form : Powder For Injectable Solution
Dosage Strength : 5MG
Packaging :
Approval Date : 1981-09-01
Application Number : 55626
Regulatory Info : Suspensed
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Injection
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Regulatory Info :
Registration Country : Italy
Brand Name : Eldisine
Dosage Form : Vindesine 5Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial EV 5 mg Groun
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Eldisine
Dosage Form : Powder For Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 16/03/1982
Application Number : 42863
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Eldisine
Dosage Form : Powder For Solution For Injection
Dosage Strength : 5mg
Packaging :
Approval Date : 06/12/1985
Application Number : 19851206000060
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Suspensed
Registration Country : Spain
Brand Name : Enison
Dosage Form : Powder For Injectable Solution
Dosage Strength : 5MG
Packaging :
Approval Date : 1981-09-01
Application Number : 55626
Regulatory Info : Suspensed
Registration Country : Spain

Regulatory Info :
Registration Country : Italy
Brand Name : Eldisine
Dosage Form : Vindesine 5Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial EV 5 mg Groun
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Injection
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Lyophilized Injection
Dosage Strength : 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1MG
Brand Name :
Approval Date :
Application Number :
Registration Country : China

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
CRINOS SpA
Dosage Form : Vindesine 5Mg 1 Unit Parenteral ...
Dosage Strength : 1 vial EV 5 mg Groun
Price Per Pack (Euro) : 187.57
Published in :
Country : Italy
RX/OTC/DISCN : Class H

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
69
PharmaCompass offers a list of Vindesine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vindesine Sulfate manufacturer or Vindesine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vindesine Sulfate manufacturer or Vindesine Sulfate supplier.
PharmaCompass also assists you with knowing the Vindesine Sulfate API Price utilized in the formulation of products. Vindesine Sulfate API Price is not always fixed or binding as the Vindesine Sulfate Price is obtained through a variety of data sources. The Vindesine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vindesine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vindesine Sulfate, including repackagers and relabelers. The FDA regulates Vindesine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vindesine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vindesine Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vindesine Sulfate supplier is an individual or a company that provides Vindesine Sulfate active pharmaceutical ingredient (API) or Vindesine Sulfate finished formulations upon request. The Vindesine Sulfate suppliers may include Vindesine Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Vindesine Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vindesine Sulfate Drug Master File in Japan (Vindesine Sulfate JDMF) empowers Vindesine Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vindesine Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Vindesine Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vindesine Sulfate suppliers with JDMF on PharmaCompass.
Vindesine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vindesine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vindesine Sulfate GMP manufacturer or Vindesine Sulfate GMP API supplier for your needs.
A Vindesine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Vindesine Sulfate's compliance with Vindesine Sulfate specifications and serves as a tool for batch-level quality control.
Vindesine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Vindesine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vindesine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vindesine Sulfate EP), Vindesine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vindesine Sulfate USP).
Contact Us!